Are down ‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity possible? ‐ A Cochrane Review summary with commentary

International Journal of Rheumatic Diseases, EarlyView.

Source: International Journal of Rheumatic Diseases - November 6, 2020 Category: Rheumatology Authors: Giovanni Morone Tags: COCHRANE CORNER Source Type: research